A new phenylethanoid glycoside from Incarvillea compacta

Area of Science:

• Phytochemistry
• Pharmacology
• Natural Products Chemistry

Background:

• Incarvillea compacta is a plant species with potential medicinal properties.
• Phenylethanoid glycosides are a class of compounds known for various biological activities.
• Oxidative stress is implicated in numerous diseases, necessitating the search for novel antioxidants.

Purpose of the Study:

• To isolate and characterize new compounds from Incarvillea compacta roots.
• To evaluate the antioxidant and cytoprotective properties of the isolated compounds.
• To identify potential therapeutic agents for oxidative stress-related conditions.

Main Methods:

• Extraction of Incarvillea compacta roots using 90% ethanol.
• Isolation of compounds using chromatographic techniques.
• Structure elucidation through spectroscopic methods (NMR, MS).
• Assessment of 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity.
• Evaluation of CCl4-induced cell death in human HepG2 cells.

Main Results:

• A new phenylethanoid glycoside, 3'''-O-methylcampneoside I (1), was isolated along with three known compounds.
• Compound 1 exhibited superior DPPH free radical scavenging activity compared to the positive control (BHT).
• Pretreatment with compound 1 significantly enhanced HepG2 cell viability against CCl4-induced toxicity.

Conclusions:

• 3'''-O-methylcampneoside I is a novel phenylethanoid glycoside with significant antioxidant and cytoprotective effects.
• Incarvillea compacta roots are a source of bioactive compounds with potential therapeutic applications.
• Compound 1 warrants further investigation for its role in combating oxidative stress and liver injury.